Harnessing cancer cell metabolism for theranostic applications using metabolic glycoengineering of sialic acid in breast cancer as a pioneering example

MLA

Haitham A. Badr, et al. “Harnessing Cancer Cell Metabolism for Theranostic Applications Using Metabolic Glycoengineering of Sialic Acid in Breast Cancer as a Pioneering Example.” Biomaterials, vol. 116, Feb. 2017, pp. 158–73. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....6050312a7ea97a9da22d20f82e8dc3df&authtype=sso&custid=ns315887.

APA

Haitham A. Badr, Motawa E. El-Houseini, Mohit P. Mathew, Christopher T. Saeui, Hafiz Ahmed, Dina M.M. AlSadek, & Kevin J. Yarema. (2017). Harnessing cancer cell metabolism for theranostic applications using metabolic glycoengineering of sialic acid in breast cancer as a pioneering example. Biomaterials, 116, 158–173.

Chicago

Haitham A. Badr, Motawa E. El-Houseini, Mohit P. Mathew, Christopher T. Saeui, Hafiz Ahmed, Dina M.M. AlSadek, and Kevin J. Yarema. 2017. “Harnessing Cancer Cell Metabolism for Theranostic Applications Using Metabolic Glycoengineering of Sialic Acid in Breast Cancer as a Pioneering Example.” Biomaterials 116 (February): 158–73. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....6050312a7ea97a9da22d20f82e8dc3df&authtype=sso&custid=ns315887.